Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1970 Apr 11;2(5701):89–90. doi: 10.1136/bmj.2.5701.89

In-vitro Comparison of Erythromycin, Lincomycin, and Clindamycin

Ian Phillips, Rosario Fernandes, Christine Warren
PMCID: PMC1699896  PMID: 4988120

Abstract

The in-vitro antibacterial activities of erythromycin, lincomycin, and clindamycin, a new derivative of lincomycin, were compared. Clindamycin was always more active than lincomycin, and was either as active as erythromycin or more so against betahaemolytic streptococci, Streptococcus viridans, Str. pneumoniae, and erythromycin-sensitive Staphylococcus aureus. It was also fully active against most erythromycin-resistant strains of Staph. aureus. On the other hand, it was somewhat less active than erythromycin against Haemophilus influenzae and considerably less active than erythromycin against Str. faecalis and Neisseria gonorrhoeae.

Clinical trials seem to be justified in infections with sensitive organisms for which erythromycin might have been indicated.

Full text

PDF
89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARBER M., WATERWORTH P. M. ANTIBACTERIAL ACTIVITY OF LINCOMYCIN AND PRISTINAMYCIN: A COMPARISON WITH ERYTHROMYCIN. Br Med J. 1964 Sep 5;2(5409):603–606. doi: 10.1136/bmj.2.5409.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. GEDDES A. M., SLEET R. A., MURDOCH J. M. LINCOMYCIN HYDROCHLORIDE: CLINICAL AND LABORATORY STUDIES. Br Med J. 1964 Sep 12;2(5410):670–672. doi: 10.1136/bmj.2.5410.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HAIGHT T. H., FINLAND M. The antibacterial action of erythromycin. Proc Soc Exp Biol Med. 1952 Oct;81(1):175–183. doi: 10.3181/00379727-81-19815. [DOI] [PubMed] [Google Scholar]
  4. McGehee R. F., Jr, Smith C. B., Wilcox C., Finland M. Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. Am J Med Sci. 1968 Nov;256(5):279–292. doi: 10.1097/00000441-196811000-00002. [DOI] [PubMed] [Google Scholar]
  5. McMillan N. L., McRae R. K., McDougall A. Lincomycin in the treatment of osteomyelitis. Practitioner. 1967 Mar;198(185):390–395. [PubMed] [Google Scholar]
  6. Meyers B. R., Kaplan K., Weinstein L. Microbiological and pharmacological behavior of 7-chlorolincomycin. Appl Microbiol. 1969 May;17(5):653–657. doi: 10.1128/am.17.5.653-657.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sanders E. Lincomycin versus erythromycin: a choice or an echo. Ann Intern Med. 1969 Mar;70(3):585–590. doi: 10.7326/0003-4819-70-3-585. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES